Key result
Continued use of the oral polio vaccine has resulted in circulating vaccine-derived polioviruses causing about eight times more polio cases than wild poliovirus between 2008 and 2024.
Why the study?
Prolonged reliance on oral polio vaccine has impeded global polio eradication due to persistent safety challenges, including vaccine-associated paralytic polio and vaccine-derived polioviruses.
Does replacing oral polio vaccine with inactivated poliovirus vaccine improve safety and facilitate global polio eradication?
Does replacing oral polio vaccine with inactivated poliovirus vaccine improve safety and facilitate global polio eradication?
Answers are grounded in this paper and cite their sources.
The paper argues for the global replacement of the oral polio vaccine with the inactivated poliovirus vaccine to eliminate vaccine-derived polio and achieve global eradication.
The excessive and prolonged reliance on Sabin oral polio vaccine (OPV) for global polio eradication by the World Health Organisation has critically impeded the mission’s success, in part due to persistent safety challenges associated with OPV. For individual children there has always been the risk of vaccine-associated paralytic polio (VAPP). For the community, the increasing risk has been genetic reversal of live vaccine viruses to neuro-virulent ‘vaccine-derived polioviruses’ (VDPVs) which cause polio far more frequently than VAPP and to ‘circulating VDPVs’ (cVDPVs) that are essentially wild polioviruses. As long as OPV is widely used, polio will not be eradicated. The way forward is to introduce the inactivated poliovirus vaccine (IPV) that is completely safe and exquisitely efficacious when given as 3-dose schedule during infancy, plus one or two boosters. Once IPV is made routine, OPV should be withdrawn country by country. Hexavalent combination vaccines including IPV are ideal, as separate injections are avoided. The sooner OPV is globally replaced with IPV, the faster global polio eradication can be achieved.
No takes yet. Share an insight, caveat, or question.
John et al. (2025) conducted an editorial in Poliomyelitis. Oral Polio Vaccine (OPV) vs. Inactivated Poliovirus Vaccine (IPV) was evaluated. Continued use of the oral polio vaccine has resulted in circulating vaccine-derived polioviruses causing about eight times more polio cases than wild poliovirus between 2008 and 2024.
Synapse has enriched 10 related papers. Consider them for comparative context: